glp-1 fatty liver Pioglitazone with SGLT2 inhibitors or receptor agonists in patients with type 2 diabetes and non-alcoholic disease: could the combinations of an old friend with new players yield better outcomes? GLP-1 and Your Liver: What

If you've got a busy lifestyle or are always on the go, injecting GLP-1 Treatments, Semaglutide or Tirzepatide at home is a game-changer

According to a study by BMC Public Health, in January 2025, the escalating prevalence of obesity-related comorbidities, particularly type 2 diabetes, is a growing global health concern

In 2025, that meant it was impossible for me to scroll through my feed without being visually assaulted by ingratiating marketing campaigns, encouraging me to shed those last few pesky pounds via drugs, specifically off-label GLP-1

Verdict: Contact the pharmacy immediately

Earlier-phase studies indicated that the drug may help reduce liver fat in people with obesity, potentially slowing the progression of NAFLD

FDA is requesting that the risk be removed from the warnings and precautions section of labeling for the GLP-1 obesity drugs Eli Lilly and Co.s Zepbound (tirzepatide) and Novo Nordisk A/S Saxenda (liraglutide) and Wegovy (semaglutide)